Clinical Trial Update: Serrantor OCT Study [NA]

View source ↗

Summary

Serrantor OCT Study, sponsored by Cagent Vascular LLC, is currently recruiting patients with Critical Limb Ischemia to evaluate the Serrantor OCT device.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Serrantor OCT

Snippet

Sponsor: Cagent Vascular LLC | Conditions: Critical Limb Ischemia | NA | Status: RECRUITING